Published in Proc Natl Acad Sci U S A on October 06, 2003
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63
Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut (2007) 2.34
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A (2009) 2.31
Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest (2007) 2.28
Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91
Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics (2012) 1.79
Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS One (2008) 1.64
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res (2005) 1.63
Apoptosis in response to microbial infection induces autoreactive TH17 cells. Nat Immunol (2016) 1.47
Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort. Clin Gastroenterol Hepatol (2015) 1.44
Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1.39
T cells in peripheral blood after gluten challenge in coeliac disease. Gut (2005) 1.36
Celiac disease: how complicated can it get? Immunogenetics (2010) 1.34
HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol (2007) 1.22
Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol (2009) 1.22
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut (2013) 1.14
Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol (2011) 1.13
The immune recognition of gluten in coeliac disease. Clin Exp Immunol (2005) 1.10
Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM. J Immunol (2008) 1.10
CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum Genet (2005) 1.06
Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics (2009) 1.05
Intrahaplotype and interhaplotype pairing of bovine leukocyte antigen DQA and DQB molecules generate functional DQ molecules important for priming CD4(+) T-lymphocyte responses. Immunogenetics (2005) 1.05
Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.05
The immunogenetics of multiple sclerosis: A comprehensive review. J Autoimmun (2015) 1.04
Celiac disease: quantity matters. Semin Immunopathol (2012) 1.03
HLA and disease. Eur J Epidemiol (2005) 1.00
Role of transglutaminase 2 in celiac disease pathogenesis. Semin Immunopathol (2012) 0.98
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics (2005) 0.96
Gluten: a two-edged sword. Immunopathogenesis of celiac disease. Springer Semin Immunopathol (2005) 0.95
Refractory celiac disease: from bench to bedside. Semin Immunopathol (2012) 0.95
On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes. Expert Rev Mol Med (2012) 0.95
Clinical practice : coeliac disease. Eur J Pediatr (2012) 0.92
Celiac disease, inflammation and oxidative damage: a nutrigenetic approach. Nutrients (2012) 0.92
Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet (2015) 0.91
Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patients. World J Gastroenterol (2014) 0.91
In vitro differentiation of human monocytes into dendritic cells by peptic-tryptic digest of gliadin is independent of genetic predisposition and the presence of celiac disease. J Clin Immunol (2008) 0.91
Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Immunogenetics (2014) 0.91
Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol (2008) 0.90
Structural and functional studies of trans-encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) protein molecule. J Biol Chem (2012) 0.88
Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective. Intern Med J (2015) 0.88
HLA dosage effect in narcolepsy with cataplexy. Immunogenetics (2014) 0.85
Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol (2014) 0.84
HLA genotyping in pediatric celiac disease patients. Bosn J Basic Med Sci (2014) 0.84
Altered gene expression in highly purified enterocytes from patients with active coeliac disease. BMC Genomics (2008) 0.83
Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat Rev Rheumatol (2015) 0.83
A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity. Clin Exp Immunol (2006) 0.82
Celiac disease and HLA in a Bedouin kindred. Hum Immunol (2006) 0.82
Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins. Eur J Nutr (2009) 0.82
Children with celiac disease and high tTGA are genetically and phenotypically different. World J Gastroenterol (2013) 0.82
Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule. Immunogenetics (2008) 0.82
Gut microbes and adverse food reactions: Focus on gluten related disorders. Gut Microbes (2014) 0.81
Comparing HLA shared epitopes in French Caucasian patients with scleroderma. PLoS One (2012) 0.81
Coeliac disease and gluten-related disorders in childhood. Nat Rev Gastroenterol Hepatol (2015) 0.80
HLA and celiac disease susceptibility: new genetic factors bring open questions about the HLA influence and gene-dosage effects. PLoS One (2012) 0.79
Latest in vitro and in vivo models of celiac disease. Expert Opin Drug Discov (2013) 0.79
Type 1 Diabetes at-risk children highly recognize Mycobacterium avium subspecies paratuberculosis epitopes homologous to human Znt8 and Proinsulin. Sci Rep (2016) 0.79
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes. Proc Natl Acad Sci U S A (2017) 0.79
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells. Clin Exp Immunol (2007) 0.78
Gene Expression Profiling of Gliadin Effects on Intestinal Epithelial Cells Suggests Novel Non-Enzymatic Functions of Pepsin and Trypsin. PLoS One (2013) 0.78
Screening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversy. Diabetol Metab Syndr (2016) 0.76
Coeliac disease: a unique model for investigating broken tolerance in autoimmunity. Clin Transl Immunology (2016) 0.75
A biased view toward celiac disease. Mucosal Immunol (2016) 0.75
Anti-actin IgA antibodies identify celiac disease patients with a Marsh 3 intestinal damage among subjects with moderate anti-TG2 levels. Biomed Res Int (2013) 0.75
Is adaptive-innate lymphocyte cross-talk driving mucosal disease? Proc Natl Acad Sci U S A (2017) 0.75
The roles of MHC class II genes and post-translational modification in celiac disease. Immunogenetics (2017) 0.75
Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther (1996) 7.12
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med (1998) 5.25
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Epidemic of coeliac disease in Swedish children. Acta Paediatr (2000) 3.94
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73
Genetic control of MHC class II expression. Cell (2002) 3.11
In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med (2000) 3.04
Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology (2002) 2.95
The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology (2002) 2.91
Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol (1998) 2.88
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med (2002) 2.49
Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med (1997) 2.11
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A (1998) 1.99
Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85
HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur J Immunol (1984) 1.73
Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics (1996) 1.71
Invited anniversary review: HLA associated diseases. Hum Immunol (1997) 1.70
Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol (1999) 1.68
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol (1999) 1.38
On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens (1993) 1.31
The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population. Eur J Gastroenterol Hepatol (1997) 1.22
Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation. Nature (1984) 1.19
Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. Immunogenetics (1997) 1.15
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A (2001) 1.11
HLA-DR and -DQ epitopes and monoclonal antibody specificity. Immunol Today (1989) 1.02
Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum Gene Ther (1997) 0.93
HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens (2002) 0.90
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med (2004) 7.10
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut (2010) 3.09
The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology (2002) 2.91
Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology (2005) 2.66
Subcellular sites for bacterial protein export. Mol Microbiol (2004) 2.50
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med (2002) 2.49
Unparalleled complexity of the MHC class I region in rhesus macaques. Proc Natl Acad Sci U S A (2005) 2.41
Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med (2014) 2.39
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci U S A (2003) 2.32
Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology (2003) 2.23
Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology (2012) 2.11
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant (2006) 2.10
The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway. J Mol Biol (2005) 2.04
Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics (2012) 1.79
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant (2012) 1.72
Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology (2002) 1.72
Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genomics (2006) 1.70
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol (2008) 1.63
Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol (2006) 1.62
Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut (2012) 1.52
Intolerance of celiac disease patients to bovine milk is not due to the presence of T-cell stimulatory epitopes of gluten. Nutrition (2008) 1.45
Celiac disease--sandwiched between innate and adaptive immunity. Hum Immunol (2006) 1.44
The molecular basis for oat intolerance in patients with celiac disease. PLoS Med (2004) 1.40
Evidence for an ancient selective sweep in the MHC class I gene repertoire of chimpanzees. Proc Natl Acad Sci U S A (2002) 1.39
Celiac disease: how complicated can it get? Immunogenetics (2010) 1.34
Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med (2011) 1.33
Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development. Proc Natl Acad Sci U S A (2007) 1.29
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med (2006) 1.17
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol (2013) 1.14
Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol (2004) 1.13
A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med (2003) 1.10
A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques. Proc Natl Acad Sci U S A (2007) 1.08
Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2. J Immunol (2008) 1.08
Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum Immunol (2005) 1.05
AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz. Proc Natl Acad Sci U S A (2010) 1.04
ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant (2005) 1.04
Differential immunogenicity of HLA mismatches in clinical transplantation. Transpl Immunol (2005) 1.03
A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease. PLoS One (2010) 1.02
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity (2012) 1.01
Reactivation by exon shuffling of a conserved HLA-DR3-like pseudogene segment in a New World primate species. Proc Natl Acad Sci U S A (2006) 1.01
Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands. J Immunol (2004) 1.01
Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol (2009) 0.97
T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics (2005) 0.96
HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides. J Immunol (2002) 0.96
Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterology (2011) 0.96
Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer. J Immunol (2011) 0.95
Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire. J Biol Chem (2011) 0.94
Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 0.91
Functional killer Ig-like receptors on human memory CD4+ T cells specific for cytomegalovirus. J Immunol (2009) 0.91
Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation. BMC Genomics (2012) 0.91
Gluten Introduction and the Risk of Coeliac Disease: A Position Paper by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2016) 0.91
The PreventCD Study design: towards new strategies for the prevention of coeliac disease. Eur J Gastroenterol Hepatol (2010) 0.90
Origin and immunophenotype of aberrant IEL in RCDII patients. Mol Immunol (2012) 0.90
Validation of a new enzyme-linked immunosorbent assay to detect the triggering proteins and peptides for celiac disease: interlaboratory study. J AOAC Int (2012) 0.89
Determination of IgG and IgA antibodies against native gliadin is not helpful for the diagnosis of coeliac disease in children up to 2 years old. J Pediatr Gastroenterol Nutr (2012) 0.89
Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variant. Hum Mol Genet (2013) 0.89
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood (2008) 0.88
The Ethiopian cereal tef in celiac disease. N Engl J Med (2005) 0.88
Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Inflamm Bowel Dis (2011) 0.88
The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. Immunology (2010) 0.87
Fine specificity of monoclonal antibodies against celiac disease-inducing peptides in the gluteome. Am J Clin Nutr (2008) 0.86
A proposed algorithm predictive for cytotoxic T cell alloreactivity. J Immunol (2012) 0.86
Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. Eur J Immunol (2004) 0.86
The influence of inherited and noninherited parental antigens on outcome after transplantation. Transpl Int (2006) 0.86
No genetic association of the human prolyl endopeptidase gene in the Dutch celiac disease population. Am J Physiol Gastrointest Liver Physiol (2005) 0.84
Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Am J Pathol (2007) 0.84
Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand J Gastroenterol (2009) 0.84
Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies. J Immunol (2005) 0.83
Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Invest Ophthalmol Vis Sci (2009) 0.82
Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule. Immunogenetics (2008) 0.82
Gluten peptides and celiac disease. Science (2003) 0.82
Enzymatic gluten detoxification: the proof of the pudding is in the eating! Trends Biotechnol (2006) 0.82
The limited storage capacity of gonadal adipose tissue directs the development of metabolic disorders in male C57Bl/6J mice. Diabetologia (2015) 0.82
Cutting edge: killer Ig-like receptors mediate "missing self" recognition in vivo. J Immunol (2009) 0.81
No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals. Hum Immunol (2006) 0.81
Gluten tolerance in adult patients with celiac disease 20 years after diagnosis? Eur J Gastroenterol Hepatol (2008) 0.81
Tef in the diet of celiac patients in The Netherlands. Scand J Gastroenterol (2008) 0.80
Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule. Mol Immunol (2009) 0.80
Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation. Int Immunol (2007) 0.80
Tissue transglutaminase: master regulator of celiac disease? J Pediatr Gastroenterol Nutr (2003) 0.79
Therapy in RCDII: Rationale for Combination Strategies? Dig Dis (2015) 0.78
HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. J Immunol (2013) 0.78
Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease. Bioorg Med Chem (2007) 0.78
Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library. Hum Immunol (2010) 0.77
DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients. J Immunol (2011) 0.77
The million-dollar question: is "gluten-free" food safe for patients with celiac disease? Am J Clin Nutr (2012) 0.77
Successful treatment of coeliac disease by allogeneic haematopoietic stem cell transplantation. J Pediatr Gastroenterol Nutr (2010) 0.76